Global CGRP Antagonists Supply, Demand and Key Producers, 2023-2029
The global CGRP Antagonists market size is expected to reach $ 10000 million by 2029, rising at a market growth of 19.1% CAGR during the forecast period (2023-2029).
The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.
This report studies the global CGRP Antagonists production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CGRP Antagonists, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGRP Antagonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CGRP Antagonists total production and demand, 2018-2029, (K Units)
Global CGRP Antagonists total production value, 2018-2029, (USD Million)
Global CGRP Antagonists production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CGRP Antagonists consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CGRP Antagonists domestic production, consumption, key domestic manufacturers and share
Global CGRP Antagonists production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CGRP Antagonists production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CGRP Antagonists production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CGRP Antagonists market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PFIZER INC(Biohaven), ABBVIE INC, Amgen, Teva, Eli Lilly and Company, Lundbeck and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGRP Antagonists market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CGRP Antagonists Market, By Region:
1. How big is the global CGRP Antagonists market?
2. What is the demand of the global CGRP Antagonists market?
3. What is the year over year growth of the global CGRP Antagonists market?
4. What is the production and production value of the global CGRP Antagonists market?
5. Who are the key producers in the global CGRP Antagonists market?
The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.
This report studies the global CGRP Antagonists production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CGRP Antagonists, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGRP Antagonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CGRP Antagonists total production and demand, 2018-2029, (K Units)
Global CGRP Antagonists total production value, 2018-2029, (USD Million)
Global CGRP Antagonists production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CGRP Antagonists consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CGRP Antagonists domestic production, consumption, key domestic manufacturers and share
Global CGRP Antagonists production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CGRP Antagonists production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CGRP Antagonists production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CGRP Antagonists market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PFIZER INC(Biohaven), ABBVIE INC, Amgen, Teva, Eli Lilly and Company, Lundbeck and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGRP Antagonists market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CGRP Antagonists Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies
- CGRP Receptor Inhibitor
- Hospital
- Clinic
- Other
- PFIZER INC(Biohaven)
- ABBVIE INC
- Amgen
- Teva
- Eli Lilly and Company
- Lundbeck
- Novartis
1. How big is the global CGRP Antagonists market?
2. What is the demand of the global CGRP Antagonists market?
3. What is the year over year growth of the global CGRP Antagonists market?
4. What is the production and production value of the global CGRP Antagonists market?
5. Who are the key producers in the global CGRP Antagonists market?
1 SUPPLY SUMMARY
1.1 CGRP Antagonists Introduction
1.2 World CGRP Antagonists Supply & Forecast
1.2.1 World CGRP Antagonists Production Value (2018 & 2022 & 2029)
1.2.2 World CGRP Antagonists Production (2018-2029)
1.2.3 World CGRP Antagonists Pricing Trends (2018-2029)
1.3 World CGRP Antagonists Production by Region (Based on Production Site)
1.3.1 World CGRP Antagonists Production Value by Region (2018-2029)
1.3.2 World CGRP Antagonists Production by Region (2018-2029)
1.3.3 World CGRP Antagonists Average Price by Region (2018-2029)
1.3.4 North America CGRP Antagonists Production (2018-2029)
1.3.5 Europe CGRP Antagonists Production (2018-2029)
1.3.6 China CGRP Antagonists Production (2018-2029)
1.3.7 Japan CGRP Antagonists Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CGRP Antagonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CGRP Antagonists Major Market Trends
2 DEMAND SUMMARY
2.1 World CGRP Antagonists Demand (2018-2029)
2.2 World CGRP Antagonists Consumption by Region
2.2.1 World CGRP Antagonists Consumption by Region (2018-2023)
2.2.2 World CGRP Antagonists Consumption Forecast by Region (2024-2029)
2.3 United States CGRP Antagonists Consumption (2018-2029)
2.4 China CGRP Antagonists Consumption (2018-2029)
2.5 Europe CGRP Antagonists Consumption (2018-2029)
2.6 Japan CGRP Antagonists Consumption (2018-2029)
2.7 South Korea CGRP Antagonists Consumption (2018-2029)
2.8 ASEAN CGRP Antagonists Consumption (2018-2029)
2.9 India CGRP Antagonists Consumption (2018-2029)
3 WORLD CGRP ANTAGONISTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CGRP Antagonists Production Value by Manufacturer (2018-2023)
3.2 World CGRP Antagonists Production by Manufacturer (2018-2023)
3.3 World CGRP Antagonists Average Price by Manufacturer (2018-2023)
3.4 CGRP Antagonists Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CGRP Antagonists Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CGRP Antagonists in 2022
3.5.3 Global Concentration Ratios (CR8) for CGRP Antagonists in 2022
3.6 CGRP Antagonists Market: Overall Company Footprint Analysis
3.6.1 CGRP Antagonists Market: Region Footprint
3.6.2 CGRP Antagonists Market: Company Product Type Footprint
3.6.3 CGRP Antagonists Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CGRP Antagonists Production Value Comparison
4.1.1 United States VS China: CGRP Antagonists Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CGRP Antagonists Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CGRP Antagonists Production Comparison
4.2.1 United States VS China: CGRP Antagonists Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CGRP Antagonists Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CGRP Antagonists Consumption Comparison
4.3.1 United States VS China: CGRP Antagonists Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CGRP Antagonists Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CGRP Antagonists Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.4.3 United States Based Manufacturers CGRP Antagonists Production (2018-2023)
4.5 China Based CGRP Antagonists Manufacturers and Market Share
4.5.1 China Based CGRP Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.5.3 China Based Manufacturers CGRP Antagonists Production (2018-2023)
4.6 Rest of World Based CGRP Antagonists Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CGRP Antagonists Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CGRP Antagonists Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CGRP Antagonists Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 CGRP Receptor Inhibitor
5.3 Market Segment by Type
5.3.1 World CGRP Antagonists Production by Type (2018-2029)
5.3.2 World CGRP Antagonists Production Value by Type (2018-2029)
5.3.3 World CGRP Antagonists Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CGRP Antagonists Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CGRP Antagonists Production by Application (2018-2029)
6.3.2 World CGRP Antagonists Production Value by Application (2018-2029)
6.3.3 World CGRP Antagonists Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 PFIZER INC(Biohaven)
7.1.1 PFIZER INC(Biohaven) Details
7.1.2 PFIZER INC(Biohaven) Major Business
7.1.3 PFIZER INC(Biohaven) CGRP Antagonists Product and Services
7.1.4 PFIZER INC(Biohaven) CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 PFIZER INC(Biohaven) Recent Developments/Updates
7.1.6 PFIZER INC(Biohaven) Competitive Strengths & Weaknesses
7.2 ABBVIE INC
7.2.1 ABBVIE INC Details
7.2.2 ABBVIE INC Major Business
7.2.3 ABBVIE INC CGRP Antagonists Product and Services
7.2.4 ABBVIE INC CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 ABBVIE INC Recent Developments/Updates
7.2.6 ABBVIE INC Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen CGRP Antagonists Product and Services
7.3.4 Amgen CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva CGRP Antagonists Product and Services
7.4.4 Teva CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company CGRP Antagonists Product and Services
7.5.4 Eli Lilly and Company CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 Lundbeck
7.6.1 Lundbeck Details
7.6.2 Lundbeck Major Business
7.6.3 Lundbeck CGRP Antagonists Product and Services
7.6.4 Lundbeck CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lundbeck Recent Developments/Updates
7.6.6 Lundbeck Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis CGRP Antagonists Product and Services
7.7.4 Novartis CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CGRP Antagonists Industry Chain
8.2 CGRP Antagonists Upstream Analysis
8.2.1 CGRP Antagonists Core Raw Materials
8.2.2 Main Manufacturers of CGRP Antagonists Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CGRP Antagonists Production Mode
8.6 CGRP Antagonists Procurement Model
8.7 CGRP Antagonists Industry Sales Model and Sales Channels
8.7.1 CGRP Antagonists Sales Model
8.7.2 CGRP Antagonists Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CGRP Antagonists Introduction
1.2 World CGRP Antagonists Supply & Forecast
1.2.1 World CGRP Antagonists Production Value (2018 & 2022 & 2029)
1.2.2 World CGRP Antagonists Production (2018-2029)
1.2.3 World CGRP Antagonists Pricing Trends (2018-2029)
1.3 World CGRP Antagonists Production by Region (Based on Production Site)
1.3.1 World CGRP Antagonists Production Value by Region (2018-2029)
1.3.2 World CGRP Antagonists Production by Region (2018-2029)
1.3.3 World CGRP Antagonists Average Price by Region (2018-2029)
1.3.4 North America CGRP Antagonists Production (2018-2029)
1.3.5 Europe CGRP Antagonists Production (2018-2029)
1.3.6 China CGRP Antagonists Production (2018-2029)
1.3.7 Japan CGRP Antagonists Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CGRP Antagonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CGRP Antagonists Major Market Trends
2 DEMAND SUMMARY
2.1 World CGRP Antagonists Demand (2018-2029)
2.2 World CGRP Antagonists Consumption by Region
2.2.1 World CGRP Antagonists Consumption by Region (2018-2023)
2.2.2 World CGRP Antagonists Consumption Forecast by Region (2024-2029)
2.3 United States CGRP Antagonists Consumption (2018-2029)
2.4 China CGRP Antagonists Consumption (2018-2029)
2.5 Europe CGRP Antagonists Consumption (2018-2029)
2.6 Japan CGRP Antagonists Consumption (2018-2029)
2.7 South Korea CGRP Antagonists Consumption (2018-2029)
2.8 ASEAN CGRP Antagonists Consumption (2018-2029)
2.9 India CGRP Antagonists Consumption (2018-2029)
3 WORLD CGRP ANTAGONISTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CGRP Antagonists Production Value by Manufacturer (2018-2023)
3.2 World CGRP Antagonists Production by Manufacturer (2018-2023)
3.3 World CGRP Antagonists Average Price by Manufacturer (2018-2023)
3.4 CGRP Antagonists Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CGRP Antagonists Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CGRP Antagonists in 2022
3.5.3 Global Concentration Ratios (CR8) for CGRP Antagonists in 2022
3.6 CGRP Antagonists Market: Overall Company Footprint Analysis
3.6.1 CGRP Antagonists Market: Region Footprint
3.6.2 CGRP Antagonists Market: Company Product Type Footprint
3.6.3 CGRP Antagonists Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CGRP Antagonists Production Value Comparison
4.1.1 United States VS China: CGRP Antagonists Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CGRP Antagonists Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CGRP Antagonists Production Comparison
4.2.1 United States VS China: CGRP Antagonists Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CGRP Antagonists Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CGRP Antagonists Consumption Comparison
4.3.1 United States VS China: CGRP Antagonists Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CGRP Antagonists Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CGRP Antagonists Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.4.3 United States Based Manufacturers CGRP Antagonists Production (2018-2023)
4.5 China Based CGRP Antagonists Manufacturers and Market Share
4.5.1 China Based CGRP Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.5.3 China Based Manufacturers CGRP Antagonists Production (2018-2023)
4.6 Rest of World Based CGRP Antagonists Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CGRP Antagonists Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CGRP Antagonists Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CGRP Antagonists Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CGRP Antagonists Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 CGRP Receptor Inhibitor
5.3 Market Segment by Type
5.3.1 World CGRP Antagonists Production by Type (2018-2029)
5.3.2 World CGRP Antagonists Production Value by Type (2018-2029)
5.3.3 World CGRP Antagonists Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CGRP Antagonists Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CGRP Antagonists Production by Application (2018-2029)
6.3.2 World CGRP Antagonists Production Value by Application (2018-2029)
6.3.3 World CGRP Antagonists Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 PFIZER INC(Biohaven)
7.1.1 PFIZER INC(Biohaven) Details
7.1.2 PFIZER INC(Biohaven) Major Business
7.1.3 PFIZER INC(Biohaven) CGRP Antagonists Product and Services
7.1.4 PFIZER INC(Biohaven) CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 PFIZER INC(Biohaven) Recent Developments/Updates
7.1.6 PFIZER INC(Biohaven) Competitive Strengths & Weaknesses
7.2 ABBVIE INC
7.2.1 ABBVIE INC Details
7.2.2 ABBVIE INC Major Business
7.2.3 ABBVIE INC CGRP Antagonists Product and Services
7.2.4 ABBVIE INC CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 ABBVIE INC Recent Developments/Updates
7.2.6 ABBVIE INC Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen CGRP Antagonists Product and Services
7.3.4 Amgen CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva CGRP Antagonists Product and Services
7.4.4 Teva CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Details
7.5.2 Eli Lilly and Company Major Business
7.5.3 Eli Lilly and Company CGRP Antagonists Product and Services
7.5.4 Eli Lilly and Company CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly and Company Recent Developments/Updates
7.5.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.6 Lundbeck
7.6.1 Lundbeck Details
7.6.2 Lundbeck Major Business
7.6.3 Lundbeck CGRP Antagonists Product and Services
7.6.4 Lundbeck CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lundbeck Recent Developments/Updates
7.6.6 Lundbeck Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis CGRP Antagonists Product and Services
7.7.4 Novartis CGRP Antagonists Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CGRP Antagonists Industry Chain
8.2 CGRP Antagonists Upstream Analysis
8.2.1 CGRP Antagonists Core Raw Materials
8.2.2 Main Manufacturers of CGRP Antagonists Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CGRP Antagonists Production Mode
8.6 CGRP Antagonists Procurement Model
8.7 CGRP Antagonists Industry Sales Model and Sales Channels
8.7.1 CGRP Antagonists Sales Model
8.7.2 CGRP Antagonists Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CGRP Antagonists Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CGRP Antagonists Production Value by Region (2018-2023) & (USD Million)
Table 3. World CGRP Antagonists Production Value by Region (2024-2029) & (USD Million)
Table 4. World CGRP Antagonists Production Value Market Share by Region (2018-2023)
Table 5. World CGRP Antagonists Production Value Market Share by Region (2024-2029)
Table 6. World CGRP Antagonists Production by Region (2018-2023) & (K Units)
Table 7. World CGRP Antagonists Production by Region (2024-2029) & (K Units)
Table 8. World CGRP Antagonists Production Market Share by Region (2018-2023)
Table 9. World CGRP Antagonists Production Market Share by Region (2024-2029)
Table 10. World CGRP Antagonists Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CGRP Antagonists Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CGRP Antagonists Major Market Trends
Table 13. World CGRP Antagonists Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CGRP Antagonists Consumption by Region (2018-2023) & (K Units)
Table 15. World CGRP Antagonists Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CGRP Antagonists Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CGRP Antagonists Producers in 2022
Table 18. World CGRP Antagonists Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CGRP Antagonists Producers in 2022
Table 20. World CGRP Antagonists Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CGRP Antagonists Company Evaluation Quadrant
Table 22. World CGRP Antagonists Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CGRP Antagonists Production Site of Key Manufacturer
Table 24. CGRP Antagonists Market: Company Product Type Footprint
Table 25. CGRP Antagonists Market: Company Product Application Footprint
Table 26. CGRP Antagonists Competitive Factors
Table 27. CGRP Antagonists New Entrant and Capacity Expansion Plans
Table 28. CGRP Antagonists Mergers & Acquisitions Activity
Table 29. United States VS China CGRP Antagonists Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CGRP Antagonists Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CGRP Antagonists Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 37. China Based CGRP Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 42. Rest of World Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 47. World CGRP Antagonists Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CGRP Antagonists Production by Type (2018-2023) & (K Units)
Table 49. World CGRP Antagonists Production by Type (2024-2029) & (K Units)
Table 50. World CGRP Antagonists Production Value by Type (2018-2023) & (USD Million)
Table 51. World CGRP Antagonists Production Value by Type (2024-2029) & (USD Million)
Table 52. World CGRP Antagonists Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CGRP Antagonists Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CGRP Antagonists Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CGRP Antagonists Production by Application (2018-2023) & (K Units)
Table 56. World CGRP Antagonists Production by Application (2024-2029) & (K Units)
Table 57. World CGRP Antagonists Production Value by Application (2018-2023) & (USD Million)
Table 58. World CGRP Antagonists Production Value by Application (2024-2029) & (USD Million)
Table 59. World CGRP Antagonists Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CGRP Antagonists Average Price by Application (2024-2029) & (US$/Unit)
Table 61. PFIZER INC(Biohaven) Basic Information, Manufacturing Base and Competitors
Table 62. PFIZER INC(Biohaven) Major Business
Table 63. PFIZER INC(Biohaven) CGRP Antagonists Product and Services
Table 64. PFIZER INC(Biohaven) CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. PFIZER INC(Biohaven) Recent Developments/Updates
Table 66. PFIZER INC(Biohaven) Competitive Strengths & Weaknesses
Table 67. ABBVIE INC Basic Information, Manufacturing Base and Competitors
Table 68. ABBVIE INC Major Business
Table 69. ABBVIE INC CGRP Antagonists Product and Services
Table 70. ABBVIE INC CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. ABBVIE INC Recent Developments/Updates
Table 72. ABBVIE INC Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen CGRP Antagonists Product and Services
Table 76. Amgen CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva CGRP Antagonists Product and Services
Table 82. Teva CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company CGRP Antagonists Product and Services
Table 88. Eli Lilly and Company CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 92. Lundbeck Major Business
Table 93. Lundbeck CGRP Antagonists Product and Services
Table 94. Lundbeck CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lundbeck Recent Developments/Updates
Table 96. Novartis Basic Information, Manufacturing Base and Competitors
Table 97. Novartis Major Business
Table 98. Novartis CGRP Antagonists Product and Services
Table 99. Novartis CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of CGRP Antagonists Upstream (Raw Materials)
Table 101. CGRP Antagonists Typical Customers
Table 102. CGRP Antagonists Typical Distributors
LIST OF FIGURE
Figure 1. CGRP Antagonists Picture
Figure 2. World CGRP Antagonists Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CGRP Antagonists Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CGRP Antagonists Production (2018-2029) & (K Units)
Figure 5. World CGRP Antagonists Average Price (2018-2029) & (US$/Unit)
Figure 6. World CGRP Antagonists Production Value Market Share by Region (2018-2029)
Figure 7. World CGRP Antagonists Production Market Share by Region (2018-2029)
Figure 8. North America CGRP Antagonists Production (2018-2029) & (K Units)
Figure 9. Europe CGRP Antagonists Production (2018-2029) & (K Units)
Figure 10. China CGRP Antagonists Production (2018-2029) & (K Units)
Figure 11. Japan CGRP Antagonists Production (2018-2029) & (K Units)
Figure 12. CGRP Antagonists Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 15. World CGRP Antagonists Consumption Market Share by Region (2018-2029)
Figure 16. United States CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 17. China CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 18. Europe CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 19. Japan CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 20. South Korea CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 22. India CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CGRP Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CGRP Antagonists Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CGRP Antagonists Markets in 2022
Figure 26. United States VS China: CGRP Antagonists Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CGRP Antagonists Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CGRP Antagonists Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 30. China Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 32. World CGRP Antagonists Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CGRP Antagonists Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies
Figure 35. CGRP Receptor Inhibitor
Figure 36. World CGRP Antagonists Production Market Share by Type (2018-2029)
Figure 37. World CGRP Antagonists Production Value Market Share by Type (2018-2029)
Figure 38. World CGRP Antagonists Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World CGRP Antagonists Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CGRP Antagonists Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World CGRP Antagonists Production Market Share by Application (2018-2029)
Figure 45. World CGRP Antagonists Production Value Market Share by Application (2018-2029)
Figure 46. World CGRP Antagonists Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. CGRP Antagonists Industry Chain
Figure 48. CGRP Antagonists Procurement Model
Figure 49. CGRP Antagonists Sales Model
Figure 50. CGRP Antagonists Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World CGRP Antagonists Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CGRP Antagonists Production Value by Region (2018-2023) & (USD Million)
Table 3. World CGRP Antagonists Production Value by Region (2024-2029) & (USD Million)
Table 4. World CGRP Antagonists Production Value Market Share by Region (2018-2023)
Table 5. World CGRP Antagonists Production Value Market Share by Region (2024-2029)
Table 6. World CGRP Antagonists Production by Region (2018-2023) & (K Units)
Table 7. World CGRP Antagonists Production by Region (2024-2029) & (K Units)
Table 8. World CGRP Antagonists Production Market Share by Region (2018-2023)
Table 9. World CGRP Antagonists Production Market Share by Region (2024-2029)
Table 10. World CGRP Antagonists Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CGRP Antagonists Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CGRP Antagonists Major Market Trends
Table 13. World CGRP Antagonists Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CGRP Antagonists Consumption by Region (2018-2023) & (K Units)
Table 15. World CGRP Antagonists Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CGRP Antagonists Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CGRP Antagonists Producers in 2022
Table 18. World CGRP Antagonists Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CGRP Antagonists Producers in 2022
Table 20. World CGRP Antagonists Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CGRP Antagonists Company Evaluation Quadrant
Table 22. World CGRP Antagonists Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CGRP Antagonists Production Site of Key Manufacturer
Table 24. CGRP Antagonists Market: Company Product Type Footprint
Table 25. CGRP Antagonists Market: Company Product Application Footprint
Table 26. CGRP Antagonists Competitive Factors
Table 27. CGRP Antagonists New Entrant and Capacity Expansion Plans
Table 28. CGRP Antagonists Mergers & Acquisitions Activity
Table 29. United States VS China CGRP Antagonists Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CGRP Antagonists Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CGRP Antagonists Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 37. China Based CGRP Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 42. Rest of World Based CGRP Antagonists Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CGRP Antagonists Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CGRP Antagonists Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CGRP Antagonists Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CGRP Antagonists Production Market Share (2018-2023)
Table 47. World CGRP Antagonists Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CGRP Antagonists Production by Type (2018-2023) & (K Units)
Table 49. World CGRP Antagonists Production by Type (2024-2029) & (K Units)
Table 50. World CGRP Antagonists Production Value by Type (2018-2023) & (USD Million)
Table 51. World CGRP Antagonists Production Value by Type (2024-2029) & (USD Million)
Table 52. World CGRP Antagonists Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CGRP Antagonists Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CGRP Antagonists Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CGRP Antagonists Production by Application (2018-2023) & (K Units)
Table 56. World CGRP Antagonists Production by Application (2024-2029) & (K Units)
Table 57. World CGRP Antagonists Production Value by Application (2018-2023) & (USD Million)
Table 58. World CGRP Antagonists Production Value by Application (2024-2029) & (USD Million)
Table 59. World CGRP Antagonists Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CGRP Antagonists Average Price by Application (2024-2029) & (US$/Unit)
Table 61. PFIZER INC(Biohaven) Basic Information, Manufacturing Base and Competitors
Table 62. PFIZER INC(Biohaven) Major Business
Table 63. PFIZER INC(Biohaven) CGRP Antagonists Product and Services
Table 64. PFIZER INC(Biohaven) CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. PFIZER INC(Biohaven) Recent Developments/Updates
Table 66. PFIZER INC(Biohaven) Competitive Strengths & Weaknesses
Table 67. ABBVIE INC Basic Information, Manufacturing Base and Competitors
Table 68. ABBVIE INC Major Business
Table 69. ABBVIE INC CGRP Antagonists Product and Services
Table 70. ABBVIE INC CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. ABBVIE INC Recent Developments/Updates
Table 72. ABBVIE INC Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen CGRP Antagonists Product and Services
Table 76. Amgen CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva CGRP Antagonists Product and Services
Table 82. Teva CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly and Company Major Business
Table 87. Eli Lilly and Company CGRP Antagonists Product and Services
Table 88. Eli Lilly and Company CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 91. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 92. Lundbeck Major Business
Table 93. Lundbeck CGRP Antagonists Product and Services
Table 94. Lundbeck CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lundbeck Recent Developments/Updates
Table 96. Novartis Basic Information, Manufacturing Base and Competitors
Table 97. Novartis Major Business
Table 98. Novartis CGRP Antagonists Product and Services
Table 99. Novartis CGRP Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of CGRP Antagonists Upstream (Raw Materials)
Table 101. CGRP Antagonists Typical Customers
Table 102. CGRP Antagonists Typical Distributors
LIST OF FIGURE
Figure 1. CGRP Antagonists Picture
Figure 2. World CGRP Antagonists Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CGRP Antagonists Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CGRP Antagonists Production (2018-2029) & (K Units)
Figure 5. World CGRP Antagonists Average Price (2018-2029) & (US$/Unit)
Figure 6. World CGRP Antagonists Production Value Market Share by Region (2018-2029)
Figure 7. World CGRP Antagonists Production Market Share by Region (2018-2029)
Figure 8. North America CGRP Antagonists Production (2018-2029) & (K Units)
Figure 9. Europe CGRP Antagonists Production (2018-2029) & (K Units)
Figure 10. China CGRP Antagonists Production (2018-2029) & (K Units)
Figure 11. Japan CGRP Antagonists Production (2018-2029) & (K Units)
Figure 12. CGRP Antagonists Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 15. World CGRP Antagonists Consumption Market Share by Region (2018-2029)
Figure 16. United States CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 17. China CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 18. Europe CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 19. Japan CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 20. South Korea CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 22. India CGRP Antagonists Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CGRP Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CGRP Antagonists Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CGRP Antagonists Markets in 2022
Figure 26. United States VS China: CGRP Antagonists Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CGRP Antagonists Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CGRP Antagonists Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 30. China Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CGRP Antagonists Production Market Share 2022
Figure 32. World CGRP Antagonists Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CGRP Antagonists Production Value Market Share by Type in 2022
Figure 34. Monoclonal Antibodies
Figure 35. CGRP Receptor Inhibitor
Figure 36. World CGRP Antagonists Production Market Share by Type (2018-2029)
Figure 37. World CGRP Antagonists Production Value Market Share by Type (2018-2029)
Figure 38. World CGRP Antagonists Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World CGRP Antagonists Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World CGRP Antagonists Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World CGRP Antagonists Production Market Share by Application (2018-2029)
Figure 45. World CGRP Antagonists Production Value Market Share by Application (2018-2029)
Figure 46. World CGRP Antagonists Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. CGRP Antagonists Industry Chain
Figure 48. CGRP Antagonists Procurement Model
Figure 49. CGRP Antagonists Sales Model
Figure 50. CGRP Antagonists Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
